Calvin Sternick

Stock Analyst at JP Morgan

(1.86)
# 3,300
Out of 5,238 analysts
19
Total ratings
38.46%
Success rate
6.19%
Average return

Stocks Rated by Calvin Sternick

U.S. Physical Therapy
Mar 19, 2025
Maintains: Overweight
Price Target: $120$110
Current: $59.29
Upside: +85.53%
Centene
Jul 10, 2024
Maintains: Neutral
Price Target: $85$80
Current: $55.96
Upside: +42.96%
PACS Group
May 6, 2024
Initiates: Overweight
Price Target: $27
Current: $33.59
Upside: -19.62%
Universal Health Services
Mar 13, 2024
Maintains: Neutral
Price Target: $144$182
Current: $169.96
Upside: +7.08%
Tenet Healthcare
Nov 17, 2023
Maintains: Overweight
Price Target: $91$81
Current: $190.38
Upside: -57.45%
Molina Healthcare
Nov 17, 2023
Maintains: Overweight
Price Target: $367$392
Current: $185.94
Upside: +110.82%